ZA931100B - A 90K tumor-associated antigen, IR-95. - Google Patents

A 90K tumor-associated antigen, IR-95.

Info

Publication number
ZA931100B
ZA931100B ZA931100A ZA931100A ZA931100B ZA 931100 B ZA931100 B ZA 931100B ZA 931100 A ZA931100 A ZA 931100A ZA 931100 A ZA931100 A ZA 931100A ZA 931100 B ZA931100 B ZA 931100B
Authority
ZA
South Africa
Prior art keywords
tumor
associated antigen
antigen
Prior art date
Application number
ZA931100A
Inventor
Stefano Lacobelli
Clara Natoli
Joseph Schlessinger
Original Assignee
Univ New York
Iversita Degli Studi G D Annun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York, Iversita Degli Studi G D Annun filed Critical Univ New York
Publication of ZA931100B publication Critical patent/ZA931100B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA931100A 1992-02-17 1993-02-17 A 90K tumor-associated antigen, IR-95. ZA931100B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920099A IT1264490B (en) 1992-02-17 1992-02-17 90K ANTIGEN ASSOCIATED WITH CANCER.

Publications (1)

Publication Number Publication Date
ZA931100B true ZA931100B (en) 1994-08-17

Family

ID=11400690

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931100A ZA931100B (en) 1992-02-17 1993-02-17 A 90K tumor-associated antigen, IR-95.

Country Status (6)

Country Link
CN (1) CN1076629A (en)
AU (2) AU3629093A (en)
IL (1) IL104745A0 (en)
IT (1) IT1264490B (en)
WO (2) WO1993017119A2 (en)
ZA (1) ZA931100B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012681A1 (en) * 1993-11-05 1995-05-11 New York University Methods relating to ir-95
CN1313603C (en) * 2004-09-30 2007-05-02 北京大学人民医院 Human ovary carcinoma resisting monoclonal antibody hybridoma cell line and its monoclonal antibody and application
GB2435882A (en) * 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies
IT1239719B (en) * 1990-04-23 1993-11-15 Univ Degli Studi Annunzio USE OF THE SP-2 MONOCLONAL ANTIBODY IN CLINICAL DIAGNOSTICS AND THE MONITORING OF THE PROGRESS OF HIV INFECTION

Also Published As

Publication number Publication date
IT1264490B (en) 1996-09-24
ITRM920099A1 (en) 1993-08-18
CN1076629A (en) 1993-09-29
WO1993017119A2 (en) 1993-09-02
IL104745A0 (en) 1993-06-10
WO1993016181A1 (en) 1993-08-19
ITRM920099A0 (en) 1992-02-17
AU3629093A (en) 1993-09-13
AU3497993A (en) 1993-09-03

Similar Documents

Publication Publication Date Title
EP0627932A4 (en) Novel antibody construct.
EP0656628A3 (en) Programmed reference.
AR244082A1 (en) Shampoo compounds.
EP0580285A3 (en) Auto-reclosers.
ZA939450B (en) A comb.
EP0703659A4 (en) Multi-rotor a.c. electrodynamic device
ZA926733B (en) 1,2-Dihydro-2-oxopyridines.
EP0676966A4 (en) Antibodies directed against binding-associated epitopes.
ZA931232B (en) A joining device.
EP0640758A3 (en) Charge forming device.
EP0649734A3 (en) Packaging.
EP0652630A3 (en) Semiconductor stack.
EP0640757A3 (en) Charge forming device.
EP0644636A3 (en) Wavelength conversion device.
EP0572808A3 (en) Antiblocage-system.
GB2272220B (en) a,w-alkanediphenols
EP0609522A3 (en) Package.
ZA937127B (en) Catch.
EP0605988A3 (en) A carrier construction.
EP0603840A3 (en) Pivot.
EP0571983A3 (en) Alpha, omega-methacrylate terminated macromonomer compounds.
ZA931100B (en) A 90K tumor-associated antigen, IR-95.
EP0579030A3 (en) Easy opening package.
EP0671665A3 (en) A sorter.
EP0634841A3 (en) Smooth spectrum spreading with a small spreading factor.